Complete Blood Counts are Frequently Abnormal 1 Year after Dosimetry-Guided Radioactive Iodine Therapy for Metastatic Thyroid Cancer

American Thyroid Association Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, 2009, Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer, Thyroid, 19, 1167, 10.1089/thy.2009.0110 Molinaro, 2009, Mild decreases in white blood cell and platelet counts are present one year after radioactive iodine remnant ablation, Thyroid., 19, 1035, 10.1089/thy.2008.0430 Alexander, 1998, Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma, J Nucl Med, 39, 1551 de Keizer, 2004, Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer, J Nucl Med., 45, 1549 Kloos, 2002, Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma, J Clin Endocrinol Metab., 87, 5817, 10.1210/jc.2002-020210 Wichers, 2000, Testicular function after radioiodine therapy for thyroid carcinoma, Eur J Nucl Med., 27, 503, 10.1007/s002590050535 Vini, 2002, Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancer, Postgrad Med J., 78, 92, 10.1136/pmj.78.916.92 Haynie, 1963, Hematologic changes observed following I-131 therapy for thyroid carcinoma, J Nucl Med., 4, 85 Günter, 1987, Long-term hematologic changes caused by radioiodine treatment of thyroid cancer. II. Bone marrow changes including leukemia [in German], Strahlenther Onkol., 163, 475 Benua, 1962, The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer, Am J Roentgenol Radium Ther Nucl Med., 87, 171 Rubino, 2003, Second primary malignancies in thyroid cancer patients, Br J Cancer., 89, 1638, 10.1038/sj.bjc.6601319 Brown, 2008, The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer, J Clin Endocrinol Metab., 93, 504, 10.1210/jc.2007-1154 Zachariah, 2001, Effect of fractionated regional external beam radiotherapy on peripheral blood cell count, Int J Radiat Oncol Biol Phys., 50, 465, 10.1016/S0360-3016(00)01587-X Robbins, 2005, The evolving role of (131)I for the treatment of differentiated thyroid carcinoma, J Nucl Med., 46, 28S Tala, 2011, Five-year survival is similar in thyroid cancer patients with distant metastases prepared for radioactive iodine therapy with either thyroid hormone withdrawal or recombinant human TSH, J Clin Endocrinol Metab., 96, 2105, 10.1210/jc.2011-0305 Robbins, 2002, A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation, J Nucl Med., 43, 1482 Tuttle, 2006, Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer, J Nucl Med., 47, 1587 Kulkarni, 2006, The relative frequency in which empiric dosages of radioiodine would potentially overtreat or undertreat patients who have metastatic well-differentiated thyroid cancer, Thyroid., 16, 1019, 10.1089/thy.2006.16.1019 Rosário, 2008, Preparation with recombinant human thyroid-stimulating hormone for thyroid remnant ablation with 131I is associated with lowered radiotoxicity, J Nucl Med., 49, 1776, 10.2967/jnumed.108.050591 Klubo-Gwiezdzinska, 2012, Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin, Thyroid., 22, 310, 10.1089/thy.2011.0235 Brincker, 1973, Induction of leukemia by 131-I treatment of thyroid carcinoma, Br J Cancer., 28, 232, 10.1038/bjc.1973.142 Edmonds, 1986, The long-term hazards of the treatment of thyroid cancer with radioiodine, Br J Radiol., 59, 45, 10.1259/0007-1285-59-697-45 Glanzmann, 1992, Subsequent malignancies in patients treated with 131-iodine for thyroid cancer, Strahlenther Onkol., 168, 337 de Vathaire, 1997, Leukaemias and cancers following iodine-131 administration for thyroid cancer, Br J Cancer., 75, 734, 10.1038/bjc.1997.130 Sandeep, 2006, Second primary cancers in thyroid cancer patients: a multinational record linkage study, J Clin Endocrinol Metab., 91, 1819, 10.1210/jc.2005-2009